The North American biomaterials market has witnessed dynamic market conditions, and is mainly driven by increased investments, funds & grants by government bodies worldwide, precipitous growth anticipated for plastic surgery and wound healing applications, inflated usage of polymers, growing number of elderly people, technological advancements, and changing lifestyles of the population.
The report ‘The North American Biomaterials market forecast 2012-2014’ analyzes the market by technology devices into four segments, such as metals, ceramics, polymers, and natural biomaterial.
Incessant rise in the number of collaborations, conferences, and research-related activities, technological advancements, and increasing applications of biomaterials are the major factors propelling the growth of the biomaterial market in this region. Immunological and inflammatory reactions, stringent regulatory systems, issue of fatigue fracture & wear, and reimbursement concerns are the major restraints curbing the biomaterial market.
The North American biomaterials market has witnessed a plethora of growth opportunities. Developments of novel biomaterials for healing wounds, plastic surgery, tissue engineering, ophthalmology, and neurology fuel the growth of this market. The burning issues affecting the growth of biomaterial market are challenges to tissue engineering and effect on suppliers by Biomaterials Access Assurance Act.
The global biomaterial market is dominated by North America, and it will continue to lead the market during the forecast period. The North American market growth will be driven by increasing government investments in the biomaterial sector, reimbursements offered by Center for Medicare and Medicaid Services (CMS), and rising aging population who are the main consumers of biomaterials. The North American biomaterial market is expected to receive a significant push due to phenomenal increase in new products such as botox, botulinum toxins, and hyaluronic-based injectables.
Some of the key players in the North American biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc., and others. The segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Customization Options
Along with the market data, you can also customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment levels
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- A comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence of plastic surgery and wound healing applications
- Country-specific patient pool of plastic surgery and wound healing applications disease (pattern analysis)
Procedure Volume Data
- Plastic surgery and wound healing procedures performed annually in each country tracked till sub-segment level
- The number of plastic surgery and wound healing procedures performed in each country
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of surgeons’ responses to market events and trends
- Pattern analysis of usage of biomaterials by physicians
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on plastic surgery data
Brand/Product Perception Matrix
- Comprehensive study of customers’ perception and behavior through our in-built social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Alternative Products: Impact analysis
MMM’s healthcare decision making quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, and preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate, and healthcare expenditure).
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Biomaterials-North America, By Applications
4.1 Split By Geography
4.1 Biomaterials-USA by Applications
4.1 Biomaterials-Canada by Applications
4.1 Biomaterials-Mexico by Applications
4.2 Other Biomaterial Applications-North America
4.2.1 Other Biomaterial Applications-North America, By Geographies
4.2.1.1 Other Biomaterial Applications-USA
4.2.1.2 Other Biomaterial Applications-Canada
4.2.1.3 Other Biomaterial Applications-Mexico
4.2.2 Other Biomaterial Applications-North America, By Types
4.2.2.1 Drug Delivery Systems Applications-North America
4.2.2.2 Urinary Applications-North America
4.2.2.3 Bariatric Surgery Applications-North America
4.2.2.4 Gastrointestinal Applications-North America
4.3 Opthalmology-North America
4.3.1 Opthalmology-North America, By Companies
4.3.1.1 Opthalmology-North America-Other Companies
4.3.1.2 Opthalmology-North America-Medtronic, Inc.
4.3.1.3 Opthalmology-North America-Biomet, Inc.
4.3.1.4 Opthalmology-North America-Stryker Corporation
4.3.1.5 Opthalmology-North America-Synthes, Inc.
4.3.2 Opthalmology-North America, By MacroIndicators
4.3.2.1 Opthalmology-Healthcare Expenditure-North America
4.3.3 Opthalmology-North America, By Geographies
4.3.3.1 Opthalmology-USA
4.3.3.2 Opthalmology-Canada
4.3.3.3 Opthalmology-Mexico
4.4 Neurological disorders/Central nervous system-North America
4.4.1 Neurological disorders/Central nervous system-North America, By Companies
4.4.1.1 Neurological disorders/Central nervous system-North America-Other Companies
4.4.1.2 Neurological disorders/Central nervous system-North America-Medtronic, Inc.
4.4.1.3 Neurological disorders/Central nervous system-North America-Biomet, Inc.
4.4.1.4 Neurological disorders/Central nervous system-North America-Stryker Corporation
4.4.1.5 Neurological disorders/Central nervous system-North America-Synthes, Inc.
4.4.2 Neurological disorders/Central nervous system-North America, By MacroIndicators
4.4.2.1 Neurological disorders/Central nervous system-Healthcare Expenditure-North America
4.4.3 Neurological disorders/Central nervous system-North America, By Geographies
4.4.3.1 Neurological disorders/Central nervous system-USA
4.4.3.2 Neurological disorders/Central nervous system-Canada
4.4.3.3 Neurological disorders/Central nervous system-Mexico
4.4.4 Neurological disorders/Central nervous system-North America, By Products
4.4.4.1 Hydrogel Scaffolds For CNS Repair-North America
4.4.4.2 Cortical Neural Prosthetics (CNP)-North America
4.4.4.3 Shunting Systems-North America
4.4.4.4 Neural Stem Cell Encapsulation-North America
4.5 Wound Healing-North America
4.5.1 Wound Healing-North America, By Companies
4.5.1.1 Wound Healing-North America-Other Companies
4.5.1.2 Wound Healing-North America-Medtronic, Inc.
4.5.1.3 Wound Healing-North America-Biomet, Inc.
4.5.1.4 Wound Healing-North America-Stryker Corporation
4.5.1.5 Wound Healing-North America-Synthes, Inc.
4.5.2 Wound Healing-North America, By MacroIndicators
4.5.2.1 Wound Healing-Healthcare Expenditure-North America
4.5.3 Wound Healing-North America, By Geographies
4.5.3.1 Wound Healing-USA
4.5.3.2 Wound Healing-Canada
4.5.3.3 Wound Healing-Mexico
4.5.4 Wound Healing-North America, By Types
4.5.4.1 Adhesion Barrier-North America
4.5.4.2 Fracture Fixation Devices-North America
4.5.4.3 Skin Substitutes-North America
4.5.4.4 Surgical Hemostats-North America
4.5.4.5 Internal Tissue Sealant-North America
4.6 Tissue Regeneration-North America
4.6.1 Tissue Regeneration-North America, By Companies
4.6.1.1 Tissue Regeneration-North America-Other Companies
4.6.1.2 Tissue Regeneration-North America-Medtronic, Inc.
4.6.1.3 Tissue Regeneration-North America-Biomet, Inc.
4.6.1.4 Tissue Regeneration-North America-Stryker Corporation
4.6.1.5 Tissue Regeneration-North America-Synthes, Inc.
4.6.2 Tissue Regeneration-North America, By MacroIndicators
4.6.2.1 Tissue Regeneration-Healthcare Expenditure-North America
4.6.3 Tissue Regeneration-North America, By Geographies
4.6.3.1 Tissue Regeneration-USA
4.6.3.2 Tissue Regeneration-Canada
4.6.3.3 Tissue Regeneration-Mexico
4.6.4 Tissue Regeneration-North America, By Products
4.6.4.1 Scaffolds for Regenerative Medicine-North America
4.6.4.2 Tailoring of Inorganic Nano-particles (gold and quantum dots with bio-active pep tides)-North America
4.6.4.3 Self-assembled Bio-mimetic Co-polymers-North America
4.6.4.4 Nano-materials for Bio-sensing Applications-North America
4.6.4.5 Cell-materials Interface Engineering-North America
4.7 Orthopedic-North America
4.7.1 Orthopedic-North America, By Companies
4.7.1.1 Orthopedic-North America-Other Companies
4.7.1.2 Orthopedic-North America-Medtronic, Inc.
4.7.1.3 Orthopedic-North America-Biomet, Inc.
4.7.1.4 Orthopedic-North America-Stryker Corporation
4.7.1.5 Orthopedic-North America-Synthes, Inc.
4.7.2 Orthopedic-North America, By MacroIndicators
4.7.2.1 Orthopedic-Healthcare Expenditure-North America
4.7.3 Orthopedic-North America, By Geographies
4.7.3.1 Orthopedic-USA
4.7.3.2 Orthopedic-Canada
4.7.3.3 Orthopedic-Mexico
4.7.4 Orthopedic-North America, By Types
4.7.4.1 Spine Biomaterial-North America
4.7.4.2 Orthobiologics biomaterials-North America
4.7.4.3 Viscosupplementation-North America
4.7.4.4 Bioresorbable Tissue Fixation Products-North America
4.7.4.5 Joint Replacement/Reconstruction-North America
4.8 Dental-North America
4.8.1 Dental-North America, By Companies
4.8.1.1 Dental-North America-Other Companies
4.8.1.2 Dental-North America-Medtronic, Inc.
4.8.1.3 Dental-North America-Biomet, Inc.
4.8.1.4 Dental-North America-Stryker Corporation
4.8.1.5 Dental-North America-Synthes, Inc.
4.8.2 Dental-North America, By MacroIndicators
4.8.2.1 Dental-Healthcare Expenditure-North America
4.8.3 Dental-North America, By Geographies
4.8.3.1 Dental-USA
4.8.3.2 Dental-Canada
4.8.3.3 Dental-Mexico
4.8.4 Dental-North America, By Products
4.8.4.1 Dental Bone Graft & Substitutes-North America
4.8.4.2 Dental Membranes-North America
4.8.4.3 Dental Implants-North America
4.8.4.4 Tissue Regeneration Materials-North America
4.9 Plastic Surgery (biomaterials)-North America
4.9.1 Plastic Surgery (biomaterials)-North America, By Companies
4.9.1.1 Plastic Surgery (biomaterials)-North America-Other Companies
4.9.1.2 Plastic Surgery (biomaterials)-North America-Medtronic, Inc.
4.9.1.3 Plastic Surgery (biomaterials)-North America-Biomet, Inc.
4.9.1.4 Plastic Surgery (biomaterials)-North America-Stryker Corporation
4.9.1.5 Plastic Surgery (biomaterials)-North America-Synthes, Inc.
4.9.2 Plastic Surgery (biomaterials)-North America, By MacroIndicators
4.9.2.1 Plastic Surgery (biomaterials)-Healthcare Expenditure-North America
4.9.3 Plastic Surgery (biomaterials)-North America, By Geographies
4.9.3.1 Plastic Surgery (biomaterials)-USA
4.9.3.2 Plastic Surgery (biomaterials)-Canada
4.9.3.3 Plastic Surgery (biomaterials)-Mexico
4.9.4 Plastic Surgery (biomaterials)-North America, By Products
4.9.4.1 Craniofacial Surgery-North America
4.9.4.2 Soft Tissue Fillers-North America
4.9.4.3 Acellular Dermal Matrices-North America
4.9.4.4 Peripheral Nerve Repair-North America
4.9.4.5 Facial Wrinkle Treatment (Hyaluronic Acid Based)-North America
4.9.4.6 Bio engineered Skins-North America
4.10 Cardiovascular applications-North America
4.10.1 Cardiovascular applications-North America, By Companies
4.10.1.1 Cardiovascular applications-North America-Other Companies
4.10.1.2 Cardiovascular applications-North America-Medtronic, Inc.
4.10.1.3 Cardiovascular applications-North America-Biomet, Inc.
4.10.1.4 Cardiovascular applications-North America-Stryker Corporation
4.10.1.5 Cardiovascular applications-North America-Synthes, Inc.
4.10.2 Cardiovascular applications-North America, By MacroIndicators
4.10.2.1 Cardiovascular applications-Healthcare Expenditure-North America
4.10.3 Cardiovascular applications-North America, By Geographies
4.10.3.1 Cardiovascular applications-USA
4.10.3.2 Cardiovascular applications-Canada
4.10.3.3 Cardiovascular applications-Mexico
4.10.4 Cardiovascular applications-North America, By Products
4.10.4.1 Cardiac Sensors-North America
4.10.4.2 Cardiac Catheters-North America
4.10.4.3 Others-Extracorporeal Oxygenation, Artificial Kidney (hemodialyzer), Ventricular Assist Device (VAD), Sternum Closure Devices, Introducer Sheaths-North America
4.10.4.4 Cardiac Stents-North America
4.10.4.5 Cardiac Guidewires-North America
4.10.4.6 Cardiac Vascular Grafts-North America
4.10.4.7 Heart Valves-North America
4.10.4.8 Implantable Cardiac Defibrillators-North America
4.10.4.9 Cardiac Pacemakers-North America
5 Biomaterials-North America, By Ingredients
5.1 Split By Geography
5.2 Biomaterials-USA by Ingredients
5.1 Biomaterials-Canada by Ingredients
5.1 Biomaterials-Mexico by Ingredients
5.2 Biomaterials-Polyhydroxyalkanoate (PHA)-North America
5.2.1 Biomaterials-Polyhydroxyalkanoate (PHA)-North America, By Geographies
5.2.1.1 Biomaterials-Polyhydroxyalkanoate (PHA)-USA
5.2.1.2 Biomaterials-Polyhydroxyalkanoate (PHA)-Canada
5.2.1.3 Biomaterials-Polyhydroxyalkanoate (PHA)-Mexico
5.3 Biomaterials-Silicones-North America
5.3.1 Biomaterials-Silicones-North America, By Ingredients
5.3.1.1 Biomaterials-Silicone-North America
5.3.1.2 Biomaterials-Silicone-North America
5.3.2 Biomaterials-Silicones-North America, By Geographies
5.3.2.1 Biomaterials-Silicones-USA
5.3.2.2 Biomaterials-Silicones-Canada
5.3.2.3 Biomaterials-Silicones-Mexico
5.4 Biomaterials-Dispersants-North America
5.4.1 Biomaterials-Dispersants-North America, By Geographies
5.4.1.1 Biomaterials-Dispersants-USA
5.4.1.2 Biomaterials-Dispersants-Canada
5.4.1.3 Biomaterials-Dispersants-Mexico
5.5 Biomaterials-Polyether Ether Ketone (PEEK)-North America
5.5.1 Biomaterials-Polyether Ether Ketone (PEEK)-North America, By Geographies
5.5.1.1 Biomaterials-Polyether Ether Ketone (PEEK)-USA
5.5.1.2 Biomaterials-Polyether Ether Ketone (PEEK)-Canada
5.5.1.3 Biomaterials-Polyether Ether Ketone (PEEK)-Mexico
5.6 Biomaterials-Microsphere-North America
5.6.1 Biomaterials-Microsphere-North America, By Geographies
5.6.1.1 Biomaterials-Microsphere-USA
5.6.1.2 Biomaterials-Microsphere-Canada
5.6.1.3 Biomaterials-Microsphere-Mexico
5.7 Biomaterials-Silicone-North America
5.7.1 Biomaterials-Silicone-North America, By Geographies
5.7.1.1 Biomaterials-Silicone-USA
5.7.1.2 Biomaterials-Silicone-Canada
5.7.1.3 Biomaterials-Silicone-Mexico
5.8 Biomaterials-Silicone-North America
5.8.1 Biomaterials-Silicone-North America, By Geographies
5.8.1.1 Biomaterials-Silicone-USA
5.8.1.2 Biomaterials-Silicone-Canada
5.8.1.3 Biomaterials-Silicone-Mexico
6 Biomaterials-North America, By Types
6.1 Split By Geography
6.3 Biomaterials-USA by Types
6.1 Biomaterials-Canada by Types
6.1 Biomaterials-Mexico by Types
6.2 Metallic Biomaterials-North America
6.2.1 Metallic Biomaterials-North America, By Types
6.2.1.1 Metallic Biomaterials-Stainless Steel-North America
6.2.1.2 Metallic Biomaterials-Titanium Alloys-North America
6.2.1.3 Metallic Biomaterials-Silver-North America
6.2.1.4 Metallic Biomaterials-Cobalt-Chrome Alloys-North America
6.2.1.5 Metallic Biomaterials-Gold-North America
6.2.1.6 Metallic Biomaterials-Platinum-North America
6.2.2 Metallic Biomaterials-North America, By Geographies
6.2.2.1 Metallic Biomaterials-USA
6.2.2.2 Metallic Biomaterials-Canada
6.2.2.3 Metallic Biomaterials-Mexico
6.2.3 Metallic Biomaterials-North America, By Materials
6.2.3.1 Cobalt-Chrome Alloys-North America
6.2.3.2 Gold-North America
6.2.3.3 Stainless Steel-North America
6.2.3.4 Titanium & Titanium Alloys-North America
6.2.3.5 Platinum-North America
6.2.3.6 Silver-North America
6.3 Ceramics Biomaterials-North America
6.3.1 Ceramics Biomaterials-North America, By Types
6.3.1.1 Ceramics Biomaterials-Calcium Phosphate-North America
6.3.1.2 Ceramics Biomaterials-Zirconium Dioxide OR Zirconia-North America
6.3.1.3 Ceramics Biomaterials-Aluminium Hydroxide OR Aluminum Trihydrate (ATH)-North America
6.3.1.4 Ceramics Biomaterials-Carbon-North America
6.3.1.5 Ceramics Biomaterials-Calcium Sulphate-North America
6.3.1.6 Ceramics Biomaterials-Glass-North America
6.3.2 Ceramics Biomaterials-North America, By Geographies
6.3.2.1 Ceramics Biomaterials-USA
6.3.2.2 Ceramics Biomaterials-Canada
6.3.2.3 Ceramics Biomaterials-Mexico
6.3.3 Ceramics Biomaterials-North America, By Materials
6.3.3.1 Carbon-North America
6.3.3.2 Calcium Sulfate-North America
6.3.3.3 Calcium Phosphate-North America
6.3.3.4 Zirconia-North America
6.3.3.5 Aluminium Oxide-North America
6.3.3.6 Glass-North America
6.4 Polymer Biomaterials-North America
6.4.1 Polymer Biomaterials-North America, By Types
6.4.1.1 Polymer Biomaterials-Polymethyl Methacrylate (PMMA)-North America
6.4.1.2 Polymer Biomaterials-Polyethylene (PE)-North America
6.4.1.3 Polymer Biomaterials-Polyester-North America
6.4.1.4 Polymer Biomaterials-Polyvinyl Chloride Resins-North America
6.4.1.5 Polymer Biomaterials-Silicone Rubber-North America
6.4.1.6 Polymer Biomaterials-Nylon-North America
6.4.2 Polymer Biomaterials-North America, By Geographies
6.4.2.1 Polymer Biomaterials-USA
6.4.2.2 Polymer Biomaterials-Canada
6.4.2.3 Polymer Biomaterials-Mexico
6.4.3 Polymer Biomaterials-North America, By Materials
6.4.3.1 Polymethylmethacrylate (PMMA)-North America
6.4.3.2 Polyvinyl Chloride-North America
6.4.3.3 Silicone Rubber-North America
6.4.3.4 Polyethylene-North America
6.4.3.5 Nylon-North America
6.4.3.6 Polyester-North America
6.5 Natural Biomaterials-North America
6.5.1 Natural Biomaterials-North America, By Types
6.5.1.1 Natural Biomaterials-Hyaluronic Acid-North America
6.5.1.2 Natural Biomaterials-Cellulose-North America
6.5.1.3 Natural Biomaterials-Chitin-North America
6.5.1.4 Natural Biomaterials-Alginates-North America
6.5.2 Natural Biomaterials-North America, By Geographies
6.5.2.1 Natural Biomaterials-USA
6.5.2.2 Natural Biomaterials-Canada
6.5.2.3 Natural Biomaterials-Mexico
6.5.3 Natural Biomaterials-North America, By Materials
6.5.3.1 Collagen & Gelatin-North America
6.5.3.2 Hyaluronic Acid-North America
6.5.3.3 Alginate-North America
6.5.3.4 Chitin-North America
6.5.3.5 Cellulose-North America
7 Biomaterials-North America, By Geographies
7.1 Biomaterials-USA
7.1.1 Biomaterials-USA, By Companies
7.1.1.1 Biomaterials-USA-Other Companies
7.1.1.2 Biomaterials-USA-Medtronic, Inc.
7.1.1.3 Biomaterials-USA-Biomet, Inc.
7.1.1.4 Biomaterials-USA-Stryker Corporation
7.1.1.5 Biomaterials-USA-Synthes, Inc.
7.1.2 Biomaterials-USA, By Ingredients
7.1.2.1 Biomaterials-Polyhydroxyalkanoate (PHA)-USA
7.1.2.2 Biomaterials-Silicone-USA
7.1.2.3 Biomaterials-Silicones-USA
7.1.2.4 Biomaterials-Dispersants-USA
7.1.2.5 Biomaterials-Polyether Ether Ketone (PEEK)-USA
7.1.2.6 Biomaterials-Microsphere-USA
7.1.3 Biomaterials-USA, By Applications
7.1.3.1 Other Biomaterial Applications-USA
7.1.3.2 Opthalmology-USA
7.1.3.3 Neurological disorders/Central nervous system-USA
7.1.3.4 Wound Healing-USA
7.1.3.5 Tissue Regeneration-USA
7.1.3.6 Orthopedic-USA
7.1.3.7 Dental-USA
7.1.3.8 Plastic Surgery (biomaterials)-USA
7.1.3.9 Cardiovascular applications-USA
7.1.4 Biomaterials-USA, By Types
7.1.4.1 Metallic Biomaterials-USA
7.1.4.2 Ceramics Biomaterials-USA
7.1.4.3 Polymer Biomaterials-USA
7.1.4.4 Natural Biomaterials-USA
7.2 Biomaterials-Canada
7.2.1 Biomaterials-Canada, By Companies
7.2.1.1 Biomaterials-Canada-Other Companies
7.2.1.2 Biomaterials-Canada-Medtronic, Inc.
7.2.1.3 Biomaterials-Canada-Biomet, Inc.
7.2.1.4 Biomaterials-Canada-Stryker Corporation
7.2.1.5 Biomaterials-Canada-Synthes, Inc.
7.2.2 Biomaterials-Canada, By Ingredients
7.2.2.1 Biomaterials-Polyhydroxyalkanoate (PHA)-Canada
7.2.2.2 Biomaterials-Silicone-Canada
7.2.2.3 Biomaterials-Silicones-Canada
7.2.2.4 Biomaterials-Dispersants-Canada
7.2.2.5 Biomaterials-Polyether Ether Ketone (PEEK)-Canada
7.2.2.6 Biomaterials-Microsphere-Canada
7.2.3 Biomaterials-Canada, By Applications
7.2.3.1 Other Biomaterial Applications-Canada
7.2.3.2 Opthalmology-Canada
7.2.3.3 Neurological disorders/Central nervous system-Canada
7.2.3.4 Wound Healing-Canada
7.2.3.5 Tissue Regeneration-Canada
7.2.3.6 Orthopedic-Canada
7.2.3.7 Dental-Canada
7.2.3.8 Plastic Surgery (biomaterials)-Canada
7.2.3.9 Cardiovascular applications-Canada
7.2.4 Biomaterials-Canada, By Types
7.2.4.1 Metallic Biomaterials-Canada
7.2.4.2 Ceramics Biomaterials-Canada
7.2.4.3 Polymer Biomaterials-Canada
7.2.4.4 Natural Biomaterials-Canada
7.3 Biomaterials-Mexico
7.3.1 Biomaterials-Mexico, By Companies
7.3.1.1 Biomaterials-Mexico-Other Companies
7.3.1.2 Biomaterials-Mexico-Medtronic, Inc.
7.3.1.3 Biomaterials-Mexico-Biomet, Inc.
7.3.1.4 Biomaterials-Mexico-Stryker Corporation
7.3.1.5 Biomaterials-Mexico-Synthes, Inc.
7.3.2 Biomaterials-Mexico, By Ingredients
7.3.2.1 Biomaterials-Polyhydroxyalkanoate (PHA)-Mexico
7.3.2.2 Biomaterials-Silicone-Mexico
7.3.2.3 Biomaterials-Silicones-Mexico
7.3.2.4 Biomaterials-Dispersants-Mexico
7.3.2.5 Biomaterials-Polyether Ether Ketone (PEEK)-Mexico
7.3.2.6 Biomaterials-Microsphere-Mexico
7.3.3 Biomaterials-Mexico, By Applications
7.3.3.1 Other Biomaterial Applications-Mexico
7.3.3.2 Opthalmology-Mexico
7.3.3.3 Neurological disorders/Central nervous system-Mexico
7.3.3.4 Wound Healing-Mexico
7.3.3.5 Tissue Regeneration-Mexico
7.3.3.6 Orthopedic-Mexico
7.3.3.7 Dental-Mexico
7.3.3.8 Plastic Surgery (biomaterials)-Mexico
7.3.3.9 Cardiovascular applications-Mexico
7.3.4 Biomaterials-Mexico, By Types
7.3.4.1 Metallic Biomaterials-Mexico
7.3.4.2 Ceramics Biomaterials-Mexico
7.3.4.3 Polymer Biomaterials-Mexico
7.3.4.4 Natural Biomaterials-Mexico
8 Biomaterials-North America, By Companies
8.1 Competitive landscape
8.2 Split By Geography
8.4 Biomaterials-USA by Companies
8.1 Biomaterials-Canada by Companies
8.1 Biomaterials-Mexico by Companies
8.3 Biomaterials-North America-Other Companies
8.3.1 Biomaterials-North America-Other Companies, By Geographies
8.3.1.1 Biomaterials-USA-Other Companies
8.3.1.2 Biomaterials-Canada-Other Companies
8.3.1.3 Biomaterials-Mexico-Other Companies
8.3.2 Biomaterials-North America-Other Companies, By Applications
8.3.2.1 Neurological disorders/Central nervous system-North America-Other Companies
8.3.2.2 Wound Healing-North America-Other Companies
8.3.2.3 Plastic Surgery (biomaterials)-North America-Other Companies
8.3.2.4 Cardiovascular applications-North America-Other Companies
8.3.2.5 Tissue Regeneration-North America-Other Companies
8.3.2.6 Orthopedic-North America-Other Companies
8.3.2.7 Dental-North America-Other Companies
8.3.2.8 Opthalmology-North America-Other Companies
8.3.3 Biomaterials-North America-Other Companies, By Types
8.3.3.1 Metallic Biomaterials-North America-Other Companies
8.3.3.2 Ceramics Biomaterials-North America-Other Companies
8.3.3.3 Polymer Biomaterials-North America-Other Companies
8.3.3.4 Natural Biomaterials-North America-Other Companies
8.4 Biomaterials-North America-Medtronic, Inc.
8.4.1 Biomaterials-North America-Medtronic, Inc., By Geographies
8.4.1.1 Biomaterials-USA-Medtronic, Inc.
8.4.1.2 Biomaterials-Canada-Medtronic, Inc.
8.4.1.3 Biomaterials-Mexico-Medtronic, Inc.
8.4.2 Biomaterials-North America-Medtronic, Inc., By Applications
8.4.2.1 Neurological disorders/Central nervous system-North America-Medtronic, Inc.
8.4.2.2 Wound Healing-North America-Medtronic, Inc.
8.4.2.3 Plastic Surgery (biomaterials)-North America-Medtronic, Inc.
8.4.2.4 Cardiovascular applications-North America-Medtronic, Inc.
8.4.2.5 Tissue Regeneration-North America-Medtronic, Inc.
8.4.2.6 Orthopedic-North America-Medtronic, Inc.
8.4.2.7 Dental-North America-Medtronic, Inc.
8.4.2.8 Opthalmology-North America-Medtronic, Inc.
8.4.3 Biomaterials-North America-Medtronic, Inc., By Types
8.4.3.1 Metallic Biomaterials-North America-Medtronic, Inc.
8.4.3.2 Ceramics Biomaterials-North America-Medtronic, Inc.
8.4.3.3 Polymer Biomaterials-North America-Medtronic, Inc.
8.4.3.4 Natural Biomaterials-North America-Medtronic, Inc.
8.5 Biomaterials-North America-Biomet, Inc.
8.5.1 Biomaterials-North America-Biomet, Inc., By Geographies
8.5.1.1 Biomaterials-USA-Biomet, Inc.
8.5.1.2 Biomaterials-Canada-Biomet, Inc.
8.5.1.3 Biomaterials-Mexico-Biomet, Inc.
8.5.2 Biomaterials-North America-Biomet, Inc., By Applications
8.5.2.1 Neurological disorders/Central nervous system-North America-Biomet, Inc.
8.5.2.2 Wound Healing-North America-Biomet, Inc.
8.5.2.3 Plastic Surgery (biomaterials)-North America-Biomet, Inc.
8.5.2.4 Cardiovascular applications-North America-Biomet, Inc.
8.5.2.5 Tissue Regeneration-North America-Biomet, Inc.
8.5.2.6 Orthopedic-North America-Biomet, Inc.
8.5.2.7 Dental-North America-Biomet, Inc.
8.5.2.8 Opthalmology-North America-Biomet, Inc.
8.5.3 Biomaterials-North America-Biomet, Inc., By Types
8.5.3.1 Metallic Biomaterials-North America-Biomet, Inc.
8.5.3.2 Ceramics Biomaterials-North America-Biomet, Inc.
8.5.3.3 Polymer Biomaterials-North America-Biomet, Inc.
8.5.3.4 Natural Biomaterials-North America-Biomet, Inc.
8.6 Biomaterials-North America-Stryker Corporation
8.6.1 Biomaterials-North America-Stryker Corporation, By Geographies
8.6.1.1 Biomaterials-USA-Stryker Corporation
8.6.1.2 Biomaterials-Canada-Stryker Corporation
8.6.1.3 Biomaterials-Mexico-Stryker Corporation
8.6.2 Biomaterials-North America-Stryker Corporation, By Applications
8.6.2.1 Neurological disorders/Central nervous system-North America-Stryker Corporation
8.6.2.2 Wound Healing-North America-Stryker Corporation
8.6.2.3 Plastic Surgery (biomaterials)-North America-Stryker Corporation
8.6.2.4 Cardiovascular applications-North America-Stryker Corporation
8.6.2.5 Tissue Regeneration-North America-Stryker Corporation
8.6.2.6 Orthopedic-North America-Stryker Corporation
8.6.2.7 Dental-North America-Stryker Corporation
8.6.2.8 Opthalmology-North America-Stryker Corporation
8.6.3 Biomaterials-North America-Stryker Corporation, By Types
8.6.3.1 Metallic Biomaterials-North America-Stryker Corporation
8.6.3.2 Ceramics Biomaterials-North America-Stryker Corporation
8.6.3.3 Polymer Biomaterials-North America-Stryker Corporation
8.6.3.4 Natural Biomaterials-North America-Stryker Corporation
8.7 Biomaterials-North America-Synthes, Inc.
8.7.1 Biomaterials-North America-Synthes, Inc., By Geographies
8.7.1.1 Biomaterials-USA-Synthes, Inc.
8.7.1.2 Biomaterials-Canada-Synthes, Inc.
8.7.1.3 Biomaterials-Mexico-Synthes, Inc.
8.7.2 Biomaterials-North America-Synthes, Inc., By Applications
8.7.2.1 Neurological disorders/Central nervous system-North America-Synthes, Inc.
8.7.2.2 Wound Healing-North America-Synthes, Inc.
8.7.2.3 Plastic Surgery (biomaterials)-North America-Synthes, Inc.
8.7.2.4 Cardiovascular applications-North America-Synthes, Inc.
8.7.2.5 Tissue Regeneration-North America-Synthes, Inc.
8.7.2.6 Orthopedic-North America-Synthes, Inc.
8.7.2.7 Dental-North America-Synthes, Inc.
8.7.2.8 Opthalmology-North America-Synthes, Inc.
8.7.3 Biomaterials-North America-Synthes, Inc., By Types
8.7.3.1 Metallic Biomaterials-North America-Synthes, Inc.
8.7.3.2 Ceramics Biomaterials-North America-Synthes, Inc.
8.7.3.3 Polymer Biomaterials-North America-Synthes, Inc.
8.7.3.4 Natural Biomaterials-North America-Synthes, Inc.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE | PUBLISHED | |
---|---|---|
North American BioProduction Market The North American bio-production Market, mainly driven by increasing in-vitro research activities, increasing demand for vaccines and cellular medicine. The report “North American Bio-Production Market forecast, 2008-2018 “analyzes the market by 5 main segments such as tissue engineering, cell culture, protein engineering, biomaterials, and micro-reactor. Geographically, the market is mainly segmented into U.S., Canada, and Mexico. The report also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming | |
European BioProduction Market The European BioProduction Market, mainly driven by increasing in-vitro research activities, increasing demand for vaccines and cellular medicine. The report “European BioProduction Market forecast, 2008-2018 “analyzes the market by 5 main segments such as tissue engineering, cell culture, protein engineering, biomaterials, and micro-reactor. Geographically, the European BioProduction Market is mainly segmented into U.K., Germany, France, Italy, Spain, and Rest of Europe. The report European BioProduction Market also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |